Unknown

Dataset Information

0

C-MYC-mediated TRIB3/P62+ aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2.


ABSTRACT: The mammalian target of rapamycin (mTOR) pathway is abnormally activated in lung cancer. However, the anti-lung cancer effect of mTOR inhibitors as monotherapy is modest. Here, we identified that ginsenoside Rh2, an active component of Panax ginseng C. A. Mey., enhanced the anti-cancer effect of the mTOR inhibitor everolimus both in vitro and in vivo. Moreover, ginsenoside Rh2 alleviated the hepatic fat accumulation caused by everolimus in xenograft nude mice models. The combination of everolimus and ginsenoside Rh2 (labeled Eve-Rh2) induced caspase-independent cell death and cytoplasmic vacuolation in lung cancer cells, indicating that Eve-Rh2 prevented tumor progression by triggering paraptosis. Eve-Rh2 up-regulated the expression of c-MYC in cancer cells as well as tumor tissues. The increased c-MYC mediated the accumulation of tribbles homolog 3 (TRIB3)/P62+ aggresomes and consequently triggered paraptosis, bypassing the classical c-MYC/MAX pathway. Our study offers a potential effective and safe strategy for the treatment of lung cancer. Moreover, we have identified a new mechanism of TRIB3/P62+ aggresomes-triggered paraptosis and revealed a unique function of c-MYC.

SUBMITTER: Su MX 

PROVIDER: S-EPMC9072243 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

c-MYC-mediated TRIB3/P62<sup>+</sup> aggresomes accumulation triggers paraptosis upon the combination of everolimus and ginsenoside Rh2.

Su Min-Xia MX   Xu Yu-Lian YL   Jiang Xiao-Ming XM   Huang Mu-Yang MY   Zhang Le-Le LL   Yuan Luo-Wei LW   Xu Xiao-Huang XH   Zhu Qi Q   Gao Jian-Li JL   Lu Jia-Hong JH   Chen Xiuping X   Huang Ming-Qing MQ   Wang Yitao Y   Lu Jin-Jian JJ  

Acta pharmaceutica Sinica. B 20210922 3


The mammalian target of rapamycin (mTOR) pathway is abnormally activated in lung cancer. However, the anti-lung cancer effect of mTOR inhibitors as monotherapy is modest. Here, we identified that ginsenoside Rh2, an active component of <i>Panax ginseng</i> C. A. Mey., enhanced the anti-cancer effect of the mTOR inhibitor everolimus both <i>in vitro</i> and <i>in vivo</i>. Moreover, ginsenoside Rh2 alleviated the hepatic fat accumulation caused by everolimus in xenograft nude mice models. The com  ...[more]

Similar Datasets

| S-EPMC5489766 | biostudies-literature
| S-EPMC8910635 | biostudies-literature
| S-EPMC4725994 | biostudies-other
| S-EPMC8838402 | biostudies-literature
| S-EPMC10193561 | biostudies-literature
| S-EPMC8431727 | biostudies-literature
| S-EPMC8546074 | biostudies-literature
| S-EPMC7725785 | biostudies-literature
| S-EPMC9894730 | biostudies-literature
| S-EPMC7661217 | biostudies-literature